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We conducted a retrospective population-based study 
of 140 episodes of Streptococcus dysgalactiae subsp. eq-
uisimilis bacteremia occurring in Finland during 1995–2004. 
Rare emm types were associated with more severe disease 
and increased mortality rates. Skin and soft tissue infections 
were more frequent clinical signs among cases caused by 
common emm types.
L
anceﬁ   eld groups C and G β-hemolytic streptococci 
(GCS and GGS) may colonize the pharynx, skin, gas-
trointestinal tract, and female genitourinary tracts (1). Ac-
cording to recent taxonomic studies, large colony-forming 
groups C and G streptococci that infect humans are classi-
ﬁ  ed as Streptococcus dysgalactiae subsp. equisimilis (2). 
S. dysgalactiae subsp. equisimilis and S. pyogenes share 
virulence factors (3,4). The M protein is an important viru-
lence factor because it confers resistance to phagocytosis 
(5). As with emm genes of S. pyogenes, the emm homologs 
of groups C and G S. dysgalactiae subsp. equisimilis are 
used for sequence-based typing (4,6,7), with >50 sequence 
types currently described (www.cdc.gov/ncidod/ biotech/
strep/emmtypes.htm). The aim of our study was to deter-
mine the clinical signs, epidemiologic characteristics, and 
emm types of S. dysgalactiae subsp. equisimilis bacteremia 
during the 10-year observation period in Finland.
The Study
We retrospectively reviewed the medical records of all 
adult patients (>16 years of age) in Pirkanmaa Health Dis-
trict, Finland, with >1 blood cultures positive for group C 
or group G S. dysgalactiae subsp. equisimilis from January 
1995 through December 2004. The Pirkanmaa Health Dis-
trict (460,000 inhabitants) has 1 tertiary care hospital (Tam-
pere University Hospital) and 4 other hospitals (Hatanpää 
City Hospital and the District Hospitals in Valkeakoski, 
Vammala, and Mänttä). Laboratory records were screened 
to identify all blood cultures positive for group C or group 
G S. dysgalactiae subsp. equisimilis during the study pe-
riod. Our case deﬁ  nition included all patients who had a 
positive blood culture for S. dysgalactiae subsp. equisimi-
lis and clinical signs compatible with septicemia. A severe 
disease was deﬁ  ned as a septicemia leading to death or 
needing intensive care unit treatment. All 128 GGS isolates 
and 12 of 18 GCS isolates were conﬁ  rmed to be S. dysga-
lactiae subsp. equisimilis. Thus, these 140 episodes of S. 
dysgalactiae subsp. equisimilis septicemia (involving 137 
patients) comprised the present study. Two of the isolates 
(1 GGS and 1 GCS) were not available for emm typing, and 
138 of the S. dysgalactiae subsp. equisimilis isolates (from 
135 patients) were sequenced to identify the emm gene.
Routine blood samples were drawn into aerobic and 
anaerobic bottles and cultivated by standard methods as re-
ported (8). S. dysgalactiae subsp. equisimilis isolates were 
further analyzed by emm typing. Nontypeable strains and 
strains isolated from patients with recurrent bacteremia 
were characterized by using pulsed-ﬁ  eld gel electrophore-
sis (PFGE).
The emm typing was performed according to the pro-
tocol of the Centers for Disease Control and Prevention 
(www.cdc.gov/ncidod/biotech/strep/strepblast.htm). If the 
emm gene could not be ampliﬁ  ed with primers 1 and 2, 
alternative primers MF1/MR1 were used (9). PFGE was 
performed as described (10). DNA proﬁ  les were analyzed 
by using Bionumerics software (Applied Maths, Kortrijk, 
Belgium) and interpreted according to the guidelines de-
scribed (11). Strains with >85% similarity were considered 
to be related types. 
SPSS software version 7.5 (SPSS, Chicago, IL, USA) 
was used for statistical analyses, and a 2-sided p value 
<0.05 was regarded as the level for signiﬁ  cance. Categori-
cal data were analyzed by χ² test or Fisher exact test as 
appropriate. Nonparametric data were analyzed by using 
the Mann-Whitney U test. Odds ratios were expressed with 
95% conﬁ  dence intervals. 
The median age of patients (73 men, 62 women) was 
67 years (range 17–90 years). Cardiovascular diseases 
(41%), diabetes (25%), and malignancies (23%) were the 
3 most prominent underlying conditions. We found 18 
emm types (including 4 subtypes of stG6: stG6.0, stG6.1, 
stG6.3, and stG6.4). StG480 (27 isolates), stG6 (23 iso-
lates), and stG485 (22 isolates) were the 3 most common 
emm types and represented 51% of all isolates (Figure 1). 
Eight of group G S. dysgalactiae subsp. equisimilis isolates 
remained nontypeable. PFGE analysis showed 2 strains to 
be related (>85% similarity). The rest of the nontypeable 
strains were sporadic (6 isolates). 
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caused by the 5 most common emm types and each repre-
senting >5% of all episodes (97 episodes, common emm 
types) and those caused by the less common or nontypable 
emm types (41 episodes, rare emm types). We could not 
ﬁ  nd an association between emm type and clinical features 
such as age or underlying disease. Severe disease was 
caused more often by rare emm types than by common emm 
types. Mortality rates were higher in patients with bacte-
remia caused by rare types than that caused by common 
types (Table 1). Four patients had recurrent S. dysgalac-
tiae subsp. equisimilis bacteremia (Table 2). PFGE proﬁ  les 
showed that strains isolated from the same patient in recur-
ring infections were identical (Figure 2). 
Common emm types were more frequently manifest-
ed as skin and soft tissue infections than were rare emm 
types, 75% vs. 54%, respectively (p = 0.012). The most 
frequent source of bacteremia was cellulitis (51%). We 
also found an association between a common emm type 
and cellulitis. Cellulitis was a more frequent clinical sign 
among patients with infections caused by common emm 
types than by rare emm types (p = 0.007); 64% of patients 
infected by common emm types had cellulitis as an initial 
clinical manifestation versus 39% of patients infected by 
rare emm types. 
Conclusions
Our study showed that mortality rates were higher in 
patients with S. dysgalactiae subsp. equisimilis bacteremia 
caused by rare emm types than in those with bacteremia 
caused by common emm types. The reason for this ﬁ  nd-
ing is unclear. One explanation for this might be that pa-
tients contract certain prevailing bacterial strains (so-called 
common types) more often, and a prior antigen challenge 
and subsequent humoral response may play a role. Severe 
disease (death or intensive care unit treatment) was also 
caused more often by rare emm types than by common emm 
types. We found also an association between a common 
emm type and cellulitis as a clinical manifestation; the com-
mon emm types were also associated with skin and soft tis-
sue infections. 
In our comprehensive study with molecular typing data 
for 138 invasive S. dysgalactiae subsp. equisimilis isolates 
from human infections, we found 18 emm types, which 
is consistent with previous reports by Cohen-Poradosu et 
al. (12) and Broyles et al. (13) . These 2 studies reported 
stG485.0. or StG6, StG245, and StG2078 as the most com-
mon emm types, respectively. Thus, emm typing provides a 
useful tool for comparative epidemiologic analysis of GGS 
isolates from various geographic regions. Our results also 
suggest that certain emm types may prevail among bacteria 
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Figure 1. emm types of 138 Streptococcus dysgalactiae subsp. equisimilis bacteremic isolates obtained during 1995–2004, Finland. NT, 
nontypeable.
Table 1. Disease severity among 138 episodes of Streptococcal dysgalactiae subsp. equisimilis bacteremia, Finland, 1995–2004*  
Disease severity 
No. (%) common emm 
types, n = 97 
No. (%) rare emm types, 
n = 41  Odds ratio (95% CI)  p value† 
30-day mortality rate  11 (11)  12 (29)  3.2 (1.3–8.1)  0.01 
Patient admitted to ICU  5 (5)  6 (15)  3.2 (0.9–11)  0.084 
Patient death or ICU treatment  12 (12)  15 (37)  4.1 (1.7–9.8)  0.001 
Hypotension‡  13 (13)  10 (24)  2.1 (0.8–5.2)  0.113 
DIC§  2 (2)  6 (15)  8.1 (1.6–42.3)  0.009 
Multiorgan failure  2 (2)  4 (10)  5.1 ( 0.9–29.2)  0.064 
STSS¶  2 (2)  4 (10)  5.1 ( 0.9–29.2)  0.064 
*CI, confidence interval; ICU, intensive care unit; DIC, disseminated intravascular coagulation; STSS, streptococcal toxic shock syndrome. Patients who 
had both clinical data and isolates available. 
†Ȥ² test or Fisher exact test as appropriate. 
‡Hypotensive (BP <90 mm Hg) at least once 0–2 days after positive blood culture. 
§Thrombocyte count <100 x 10
9/L. 
¶The definition of STSS was based on a consensus definition, including identification of E-hemolytic streptococci from a normally sterile site, septic shock, 
and multiorgan failure. S. dysgalactiae subsp. equisimilis Bacteremia
that cause human infections. Our study did not show any 
obvious time shifts in the occurrence of certain emm types. 
A noteworthy ﬁ  nding in our series was the high fre-
quency of recurrent group G S. dysgalactiae subsp. eq-
uisimilis bacteremia as reported earlier (12,14). Clini-
cians should be alert to this phenomenon, which seems 
to be more common than recurrent group A streptococcal 
bacteremia. 
The dynamics of interspecies transfer of virulence loci 
between group A streptococci, GGS, and GCS (3), as well 
as potential genetic transfer or intragenomic events causing 
interconversion of group antigen types, remains to be re-
solved. Further characterization of the strains by multilocus 
sequence typing would be of interest (15). 
We conclude that severity of disease and mortality 
rates were higher in persons with S. dysgalactiae subsp. 
equisimilis bacteremia caused by rare emm types than that 
caused by common emm types. Skin and soft tissue infec-
tions such as cellulitis were signiﬁ  cantly more frequent 
clinical signs among episodes caused by common emm 
types. 
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Table 2. Characteristics of recurrent episodes of group G Streptococcal dysgalactiae subsp. equisimilis bacteremia, Finland, 1995–
2004*
Patient
no.
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4 stG480 NA‡ 21 Cellulitis Unique 
*PFGE, pulsed-field gel electrophoresis. 
†Blood culture taken outside Pirkanmaa Health District, isolate available.  
‡Blood culture taken outside Pirkanmaa Health District, no isolate available.  
1997 Nov 11 stG480 3 2
Date emm type   Patient  Episode
1997 Nov 11 stG480 3 2
1995 Jul 24 stG480 3 1
1998 Oct 18 stG480 4 1
1997 Aug 12 stG6 2 1
2003 May 17 stG6 2 2 2003 May 17 stG6 2 2
2002 Oct 15 stG6 1 1
2004 Jan 8     stG6 1        2
2004 Apr 10   stG6 1 3
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patients with recurrent group G 
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